论文部分内容阅读
目的探讨欣母沛在预防治疗产后出血中的临床价值。方法半随机选择96例有剖宫产指征且有宫缩乏力高危因素的待产孕妇,分为两组:观察组48例应用欣母沛,对照组48例使用缩宫素及米索前列醇,对比分析两组用药后的临床效果及不良反应。结果观察组胎盘娩出前后出血量、产后2 h内出血量及产后出血>400 ml发生率、药物不良反应均明显少于对照组,差异有统计学意义(P<0.05)。结论应用欣母沛预防治疗产后出血临床效果满意,值得临床推广。
Objective To explore the clinical value of Yan-Pei Pei in the prevention and treatment of postpartum hemorrhage. Methods A total of 96 randomly selected pregnant women with cesarean indications and high risk factors for uterine atony were divided into two groups: 48 cases in the observation group were treated with Xin Mapei and 48 cases in the control group were treated with oxytocin and misoprostol , Comparative analysis of two groups of clinical efficacy and adverse reactions. Results The amount of bleeding in the observation group before and after delivery of the placenta, the amount of bleeding within 2 h postpartum and the incidence of postpartum hemorrhage> 400 ml were all significantly lower than those in the control group (P <0.05). Conclusion The application of Xin Maopeng prevention and treatment of postpartum hemorrhage clinical results are satisfactory, worthy of clinical promotion.